BMS, Sanofi Get Gene Patent Partially Invalidated In IP Suit
A Delaware federal judge invalidated part of a DNA technology patent Genetic Technologies Ltd. accused Bristol-Myers Squibb Co. and a Sanofi-Aventis SA unit of infringing because it merely described a natural...To view the full article, register now.
Already a subscriber? Click here to view full article